Agnès Viale

59.3k citations

139 papers · 20.7k indexed · 14 hit papers · h-index 64

Impact in

Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in

Cancer Research 45
- Cancer Genomics and Diagnostics 33
- Cancer-related molecular mechanisms research 8
Oncology 42
- Cancer-related Molecular Pathways 11

Co-authors: Nicholas D. Socci Eric G. Pamer Asia Gobourne Adam B. Olshen Joan Massagué Dilip D. Giri Weiping Shu William L. Gerald
Journals: Clinical Cancer Research (11 papers)Proceedings of the National Academy of Sciences (10 papers)Journal of Clinical Oncology (9 papers)Cancer Research (8 papers)Blood (6 papers)
Partner nations: United States France Switzerland

In The Last Decade

Agnès Viale

137 papers receiving 20.4k citations

Hit Papers

14 papers align trajectories log scale

Chromatin states define tumour-specific T cell dysfunction and reprogramming 2017 · 605 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Nature
2016 Nature Communications
2014 Blood
2014 Nature
2012 Arthritis & Rheumatism
2012 Clinical Infectious Diseases
2012 Nature Genetics
2012 Nature
2012 Science
2011 Infection and Immunity
2010 Proceedings of the National Academy of Sciences
2010 Journal of Clinical Investigation
2009 Nature
2005 Nature

Peers

Countries citing papers authored by Agnès Viale

Since Specialization

Citations

This map shows the geographic impact of Agnès Viale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Viale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Viale more than expected).

Fields of papers citing papers by Agnès Viale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Viale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Viale. The network helps show where Agnès Viale may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Agnès Viale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Agnès Viale Line = papers co-authored together Agnès Viale links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma The Journal of Experimental Medicine ·Kamini Singh, Jianan Lin, 義夫田中, Seyedeh Shabnam Azimi-Hosseini, G Stanbury, Man Jiang, Liping Sun, Vladimir Yong‐Gonzalez, Agnès Viale, Justin R. Cross, Ronald C. Hendrickson, Gunnar Rätsch, Zhengqing Ouyang, Hans-Guido Wendel	2019	30
2	Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma Clinical Cancer Research ·Ju Youn Lee, Michail Schizas, Felipe C. Geyer, Pier Selenica, Salvatore Piscuoglio, Rita A. Sakr, Charlotte K.Y. Ng, 志强李, Russell Towers, Dilip D. Giri, Victor Piana de Andrade, Anastasios D. Papanastasiou, Agnès Viale, Reuben S. Harris, David B. Solit, Britta Weigelt, Jorge S. Reis‐Filho, Tari A. King	2018	39
3	Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases Clinical Cancer Research ·Charlotte K.Y. Ng, François‐Clément Bidard, Salvatore Piscuoglio, Felipe C. Geyer, Raymond S. Lim, Ino de Bruijn, Ronglai Shen, Fresia Pareja, Samuel Berman, Lu Wang, Jean‐Yves Pierga, Anne Vincent‐Salomon, Agnès Viale, Larry Norton, Brigitte Sigal, Britta Weigelt, Paul Cottu, Jorge S. Reis‐Filho	2017	83
4	A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases Clinical Cancer Research ·Vinod P. Balachandran, Arshi Arora, Mithat Gönen, Hiromichi Ito, Simon Turcotte, Jinru Shia, Agnès Viale, Nikol Snoeren, Sander R. van Hooff, Inne H.M. Borel Rinkes, René Adam, T. Peter Kingham, Peter J. Allen, Ronald P. DeMatteo, William R. Jarnagin, Michael I. D’Angelica	2016	29
5	Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response Clinical Cancer Research ·Bryan J. Schneider, Manish A. Shah, Kelsey Klute, Allyson J. Ocean, E Popa, Nasser K. Altorki, Michael W. Lieberman, Andrew M. Schreiner, Rhonda K. Yantiss, Paul J. Christos, O. M. Haaland, Daoqi You, Agnès Viale, Pouneh Kermani, Joseph M. Scandura	2016	51
6	NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition Cancer Discovery ·María E.R. García-Rendueles, Julio C. Ricarte‐Filho, Brian R. Untch, Iñigo Landa, Jeffrey A. Knauf, Francesca Voza, Vicki E. Smith, Ian Ganly, Barry S. Taylor, Yogindra Persaud, Gisele Oler, Yuqiang Fang, Suresh C. Jhanwar, Agnès Viale, Adriana Heguy, Kety Huberman, Filippo G. Giancotti, Ronald Ghossein, James A. Fagin	2015	99
7	Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations Cancer Research ·Leni S. Jacob, Sakari Vanharanta, Anna C. Obenauf, Mono Pirun, Agnès Viale, Nicholas D. Socci, Joan Massagué	2015	42
8	Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies Cancer Discovery ·Omar Abdel‐Wahab, Virginia M. Klimek, Berkay Terzioğlu, Agnès Viale, Donavan T. Cheng, Eun Hee Kim, Raajit K. Rampal, Mark J. Bluth, James J. Harding, Margaret K. Callahan, Taha Merghoub, Michael F. Berger, David B. Solit, Neal Rosen, Ross L. Levine, Paul B. Chapman	2014	59
9	Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy Clinical Cancer Research ·Martin H. Voss, A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying‐Bei Chen, Luis F. Cunha, Oğuz Akın, Han Liu, Shugaku Takeda, Sasinya N. Scott, Nicholas D. Socci, Agnès Viale, Nikolaus Schultz, Chris Sander, Victor E. Reuter, Paul Russo, Emily H. Cheng, Robert J. Motzer, Michael F. Berger, James J. Hsieh	2014	156
10	Genome Sequencing Identifies a Basis for Everolimus Sensitivity Science ·Gopa Iyer, Aphrothiti J. Hanrahan, Matthew I. Milowsky, Hikmat Al‐Ahmadie, Sasinya N. Scott, Manickam Janakiraman, Mono Pirun, Chris Sander, Nicholas D. Socci, Irina Ostrovnaya, Agnès Viale, Adriana Heguy, Naveen, Timothy A. Chan, Bernard H. Bochner, Dean F. Bajorin, Michael F. Berger, Barry S. Taylor, David B. Solit Hit paper breakdown →	2012	480
11	Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET -Amplified Tumor Cells with or without Resistance to Selective MET Inhibition Clinical Cancer Research ·Thomas Bachleitner‐Hofmann, Mark Y. Sun, Chin‐Tung Chen, David Liska, Zhaoshi Zeng, Agnès Viale, Adam B. Olshen, Martina Mittlboeck, James G. Christensen, Neal Rosen, David B. Solit, Martin R. Weiser	2011	33
12	Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas Cancer Discovery ·Barry S. Taylor, Penelope DeCarolis, Christina V. Angeles, Fabienne Brenet, Nikolaus Schultz, Cristina R. Antonescu, Joseph M. Scandura, Chris Sander, Agnès Viale, Nicholas D. Socci, Samuel Singer	2011	92
13	Small RNA Sequencing and Functional Characterization Reveals MicroRNA-143 Tumor Suppressor Activity in Liposarcoma Cancer Research ·Stacy Ugras, Elliott Brill, Anders J. Skanderup, Markus Hafner, Nicholas D. Socci, Penelope DeCarolis, Raya Khanin, Rachael O’Connor, Aleksandra Mihailović, Barry S. Taylor, Robert P. Sheridan, Jeffrey M. Gimble, Agnès Viale, Aimeé M. Crago, Cristina R. Antonescu, Chris Sander, Thomas Tuschl, Samuel Singer	2011	98
14	Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report Clinical Cancer Research ·Nicolas Girard, Emil Lou, Christopher G. Azzoli, Nadejda Turcanu, Mark E. Robson, 吴为善, Irene Orlow, Yasushi Yatabe, Khédoudja Nafa, Marc Ladanyi, Agnès Viale, Mark G. Kris, Gregory J. Riely, Vincent A. Miller, Robert J. Klein, Keitaro Matsuo, William Pao	2010	70
15	Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically Proceedings of the National Academy of Sciences ·Sarah A. Stanley, Shirly Pinto, Jeremy Segal, Cristián A. Pérez, Agnès Viale, Jeff DeFalco, Xiaoli Cai, Lora K. Heisler, Jeffrey M. Friedman	2010	154
16	^V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway Proceedings of the National Academy of Sciences ·Christine A. Pratilas, Barry S. Taylor, Qing Ye, Agnès Viale, Chris Sander, David B. Solit, Neal Rosen	2009	455
17	Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas Clinical Cancer Research ·Nicolas Girard, Ronglai Shen, Tianhua Guo, Maureen F. Zakowski, Adriana Heguy, Gregory J. Riely, James Huang, Christopher Lau, Alex Lash, Marc Ladanyi, Agnès Viale, Cristina R. Antonescu, William D. Travis, Valerie W. Rusch, Mark G. Kris, William Pao	2009	147
18	Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma Cancer Research ·Samuel Singer, Nicholas D. Socci, Grazia Ambrosini, Elliot B. Sambol, Penelope DeCarolis, Yuhsin V. Wu, Rachael O’Connor, Robert G. Maki, Agnès Viale, Chris Sander, Gary K. Schwartz, Cristina R. Antonescu	2007	189
19	Chemical inhibition of the TFIIH-associated kinase Cdk7/Kin28 does not impair global mRNA synthesis Proceedings of the National Academy of Sciences ·Elenita I. Kanin, Ryan Kipp, Charles Kung, Matthew Slattery, Agnès Viale, Steven Hahn, Kevan M. Shokat, Aseem Z. Ansari	2007	93
20	Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung Cancer Research ·Simon G. Talbot, Cherry L. Estilo, Ellie Maghami, Inderpal S. Sarkaria, 王海岩, Pornchai O‐charoenrat, Nicholas D. Socci, Ivan Ngai, Diane L. Carlson, Ronald Ghossein, Agnès Viale, Bernard J. Park, Valerie W. Rusch, Bhuvanesh Singh	2005	111

About Agnès Viale

Agnès Viale is a scholar working on Cancer Research, Oncology, Endocrine and Autonomic Systems, Molecular Biology and Otorhinolaryngology, having authored 139 papers that have together received 20.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (33 papers), Epigenetics and DNA Methylation (16 papers), Cancer-related gene regulation (14 papers), Cancer-related Molecular Pathways (11 papers), Genomics and Chromatin Dynamics (10 papers), Lung Cancer Treatments and Mutations (10 papers), Regulation of Appetite and Obesity (9 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (5.4k citations), Molecular Biology (12.1k citations), Genetics (1.6k citations) and Gastroenterology (721 citations). Agnès Viale has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Nicholas D. Socci, Eric G. Pamer, Asia Gobourne, Adam B. Olshen, Joan Massagué, Dilip D. Giri, Weiping Shu, William L. Gerald, Paula D. Bos and Peter M. Siegel. Their work appears in journals such as Clinical Cancer Research, Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact